INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIA
Investigation of the Genetic Etiology of Hernia Sac Development in Male Children With Undescended Testis and Inguinal Hernia
1 other identifier
observational
3
1 country
1
Brief Summary
The aim of the project is to elucidate the genetic etiology underlying the development of the processus vaginalis (PV) in male children with indirect inguinal hernia (IIH) and undescended testis (UT), through the investigation of potential variants in the INSL3, WT1, and GATA6 genes using next-generation sequencing (NGS), and to explore possible differences in the tissue-level expression of these genes by real-time PCR analysis. Indirect inguinal hernia represents a significant clinical problem for human health, due to its high prevalence in the population and its potential to cause life-threatening conditions or permanent functional loss. The treatment of both of these conditions, under current circumstances, requires surgical intervention. In the course of IIH, segmental loss of reproductive organs and intestines in both girls and boys, together with ischemia-reperfusion injury occurring in these tissues, constitute serious medical complications that cannot be overlooked. Furthermore, the substantial economic cost associated with the management of such severe complications necessitates meticulous control of the process. UT, on the other hand, is being observed with increasing frequency today and represents a significant health problem in society, as it is closely associated with reproductive disorders. Clarifying the mechanisms underlying the pathogenesis of both inguinal region diseases will make a critical contribution not only to protecting individual health, but also to advancing societal well-being and scientific knowledge. Moreover, the data obtained from this study are expected to provide new perspectives for IIH and UT treatment approaches and form a scientific basis for future studies in the field. This prospective cross-sectional study will comprise 20 patients with indirect inguinal hernia, 20 patients with undescended testis, and 20 patients undergoing circumcision, consecutively admitted to the Department of Pediatric Surgery, Faculty of Medicine, Trakya University. Patent processus vaginalis tissues excised during surgery from patients with IIH and UT, and preputial tissues obtained from patients in the circumcision group, will be collected. Tissue and blood samples taken from the patients will be transferred to the Department of Medical Genetics, Faculty of Medicine, Trakya University, for further analyses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2026
CompletedFirst Submitted
Initial submission to the registry
April 30, 2026
CompletedFirst Posted
Study publicly available on registry
May 14, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
ExpectedMay 14, 2026
April 1, 2026
7 months
April 30, 2026
May 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification of Genetic Variants in INSL3, WT1, and GATA6 Genes
Investigation of potential genetic variants and mutations in INSL3, WT1, and GATA6 genes using Next-Generation Sequencing (NGS) from both processus vaginalis (PV) tissues and genomic DNA obtained from leukocytes.
Up to 3 months after completion of the study
Secondary Outcomes (1)
Analysis of Gene Expression Levels in Processus Vaginalis Tissues
Up to 3 months after completion of the study
Eligibility Criteria
Patients who present to the Pediatric Surgery Outpatient Clinic of Trakya University Faculty of Medicine between September 2025 and September 2026, including 20 diagnosed with IIH, 20 diagnosed with IT, and 20 presenting for circumcision, and for whom informed consent has been obtained, will be consecutively enrolled in the study.
You may qualify if:
- All pediatric age groups
- Patients with Indirect Inguinal Hernia without additional systemic or inguinoscrotal diseases
- Patients with Undescended Testis without additional systemic or inguinoscrotal diseases
- Patients requesting circumcision without additional systemic or inguinoscrotal diseases
- Healthy children undergoing circumcision for traditional reasons
You may not qualify if:
- Patients with recurrence, hydrocele, prior abdominal/inguinoscrotal surgery, genetic disorders, or incarcerated/strangulated IIH
- Any syndromic disease
- Bilateral IIH patients
- Bilateral UT patients
- Patients with hypospadias, micropenis, disorders of sex development, or genitourinary anomalies/diseases
- Presence of umbilical, femoral, Spigelian, or lumbar hernia
- History of premature birth
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Trakya University Faculty of Medicine, Department of Pediatric Surgery
Edirne, 22020, Turkey (Türkiye)
Biospecimen
Patent processus vaginalis and preputial tissue samples for mRNA expression analysis, and peripheral blood samples stored for DNA variation analysis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 14 Days
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
April 30, 2026
First Posted
May 14, 2026
Study Start
September 9, 2025
Primary Completion
April 10, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
May 14, 2026
Record last verified: 2026-04